Jordan University Hospital
Amman, 11942, Jordan
NCT Number: NCT04145063
This study aims to compare three groups of patients who underwent uncomplicated ureteroscopic lithotripsy (URSL) to evaluate whether stents could be eliminated after the procedure
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Amman, 11942, Jordan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
following uretroscopy, no stent will be placed
Time frame: 1 week
Visual Analog Score (VAS) for flank pain and dysuria score, urgency, frequency, suprapubic pain, hematuria, analgesia requirement, operative time, re-hospitalization, and return to normal physical activity. This is a widely-used scale. It a unidimensional measure of pain intensity. It is administered as a straight horizontal line orientated from the left (worst) to the right (best) , where the patient indicates their situation.
University of Jordan
Other
Ureteric Stenting Versus Non-stenting Following Uncomplicated Ureteroscopic Lithotripsy: A Prospective Randomized Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06101563
Calculi, Female Urogenital Diseases
Al Mansurah, Egypt
View Trial DetailsNCT06147817
Childhood, Female Urogenital Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT06110247
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Ankara, Çankaya, Turkey (Türkiye)
View Trial DetailsNCT05725226
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Kathmandu, Bagmati, Nepal
View Trial Details